Kazia Therapeutics's market cap is currently $12.80M. The company's EPS TTM is $; its P/E ratio is -0.26; Kazia Therapeutics is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is
gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.